Patents by Inventor Mark A. Bowe

Mark A. Bowe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12141857
    Abstract: Methods and systems for managing modifications to aircraft using a graphical user interface. A navigation section is displayed in the graphical user interface and includes at least one of a models menu control or a scenarios menu control. The models menu control is selectable to present model options to a user, the model options being customized based on at least one of identification information associated or customer information. The scenarios menu control is selectable to present scenario options to a user, the scenario options being tailored for the customer based on the at least one of identification information associated with the user or customer information retrieved for the customer. An effectivity selector allows the user to select a set of aircraft for modification. Based on the set of aircraft selected, features displayed in the graphical user interface based on an option from the model or scenario options are customized automatically.
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: November 12, 2024
    Assignee: The Boeing Company
    Inventors: Patrick C. Fahey, Sheldon D. Gilley, Mark A. Bowe
  • Patent number: 11605122
    Abstract: Methods and systems for managing aircraft modifications. A link to a customer information database is established in response to receiving a launch input for a modification marketplace entered by a user via a graphical user interface. The customer information database includes identification information and customer information associated with the user. A determination is made as to whether the user is authorized to access the modification marketplace using the identification information. A link to an engineering database containing aircraft product information is established in response to a determination that the user is authorized to access the modification marketplace. A selected level of access to the aircraft product information in the engineering database is provided, via the graphical user interface, based on the customer information associated with the user.
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: March 14, 2023
    Assignee: The Boeing Company
    Inventors: Patrick C. Fahey, Sheldon D. Gilley, Mark A. Bowe
  • Publication number: 20200134686
    Abstract: Methods and systems for managing modifications to aircraft using a graphical user interface. A navigation section is displayed in the graphical user interface and includes at least one of a models menu control or a scenarios menu control. The models menu control is selectable to present model options to a user, the model options being customized based on at least one of identification information associated or customer information. The scenarios menu control is selectable to present scenario options to a user, the scenario options being tailored for the customer based on the at least one of identification information associated with the user or customer information retrieved for the customer. An effectivity selector allows the user to select a set of aircraft for modification. Based on the set of aircraft selected, features displayed in the graphical user interface based on an option from the model or scenario options are customized automatically.
    Type: Application
    Filed: September 17, 2019
    Publication date: April 30, 2020
    Inventors: Patrick C. Fahey, Sheldon D. Gilley, Mark A. Bowe
  • Publication number: 20200134704
    Abstract: Methods and systems for managing aircraft modifications. A link to a customer information database is established in response to receiving a launch input for a modification marketplace entered by a user via a graphical user interface. The customer information database includes identification information and customer information associated with the user. A determination is made as to whether the user is authorized to access the modification marketplace using the identification information. A link to an engineering database containing aircraft product information is established in response to a determination that the user is authorized to access the modification marketplace. A selected level of access to the aircraft product information in the engineering database is provided, via the graphical user interface, based on the customer information associated with the user.
    Type: Application
    Filed: September 17, 2019
    Publication date: April 30, 2020
    Inventors: Patrick C. Fahey, Sheldon D. Gilley, Mark A. Bowe
  • Publication number: 20200134705
    Abstract: Methods and systems for building a configuration for a new aircraft. A link to a customer information database is established in response to receiving a launch input for a production marketplace entered by a user via a graphical user interface. The user is associated with a customer. The customer information database includes identification information associated with the user. A determination is made as to whether the user is authorized to access the production marketplace using the identification information user. Guidance information is generated for presentation via the graphical user interface to guide the user through a build process for building the configuration in response to the user being authorized to access the production marketplace, the guidance information being customized for the customer. Feature selections are received by the user via the graphical user interface. The configuration is built for the new aircraft based on the feature selections.
    Type: Application
    Filed: September 17, 2019
    Publication date: April 30, 2020
    Inventors: Patrick C. Fahey, Sheldon D. Gilley, Mark A. Bowe
  • Publication number: 20150182589
    Abstract: The invention provides, among other aspects, compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; diseases or conditions associated with an abnormal level or activity of collagen VI; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); and disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation.
    Type: Application
    Filed: August 29, 2014
    Publication date: July 2, 2015
    Inventors: Justin R. Fallon, Michael Rafii, Mark A. Bowe, Beth A. McKechnie, Alison R. Amenta, Mary Lynn Mercado, Hiroki Hagiwara
  • Patent number: 8822418
    Abstract: The invention provides, among other aspects, compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; diseases or conditions associated with an abnormal level or activity of collagen VI; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); and disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: September 2, 2014
    Assignee: Brown University
    Inventors: Justin R. Fallon, Michael Rafii, Mark A. Bowe, Beth McKechnie, Alison Amenta, Mary Lynn Mercado, Hiroki Hagiwara
  • Patent number: 8691766
    Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.
    Type: Grant
    Filed: February 8, 2012
    Date of Patent: April 8, 2014
    Assignee: Brown University Research Foundation
    Inventors: Justin R. Fallon, Beth A. McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Alison R. Amenta, Mary Lynn Mercado, Hiroki Hagiwara
  • Patent number: 8658596
    Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Examples of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: February 25, 2014
    Assignee: Brown University Research Foundation
    Inventors: Justin R. Fallon, Mark A. Bowe, Beth McKechnie, Michael Rafii, Alison Amenta, Mary Lynn Mercado, Hiroki Hagiwara
  • Publication number: 20120245095
    Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.
    Type: Application
    Filed: February 8, 2012
    Publication date: September 27, 2012
    Applicant: Brown University Research Foundation
    Inventors: Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Alison Amenta, Mary Lynn Mercado, Hiroki Hagiwara
  • Patent number: 8138154
    Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.
    Type: Grant
    Filed: July 6, 2009
    Date of Patent: March 20, 2012
    Assignee: Brown University Research Foundation
    Inventors: Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Alison Amenta, Mary Lynn Mercado, Hiroki Hagiwara
  • Publication number: 20110183910
    Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Examples of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.
    Type: Application
    Filed: September 14, 2010
    Publication date: July 28, 2011
    Applicant: Brown University Research Foundation
    Inventors: Justin R. Fallon, Mark A. Bowe, Beth McKechnie, Michael Rafii, Alison Amenta, Mary Lynn Mercado, Hiroki Hagiwara
  • Publication number: 20110053854
    Abstract: The invention provides, among other aspects, compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; diseases or conditions associated with an abnormal level or activity of collagen VI; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); and disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation.
    Type: Application
    Filed: May 24, 2010
    Publication date: March 3, 2011
    Inventors: Justin R. Fallon, Michael Rafii, Mark A. Bowe, Beth McKechnie, Alison Amenta, Mary Lynn Mercado, Hiroki Hagiwara
  • Patent number: 7816322
    Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Examples of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.
    Type: Grant
    Filed: February 22, 2008
    Date of Patent: October 19, 2010
    Assignee: Brown University Research Foundation
    Inventors: Justin R. Fallon, Mark A. Bowe, Beth McKechnie, Michael Rafii, Alison Amenta, Mary Lynn Mercado, Hiroki Hagiwara
  • Publication number: 20100130405
    Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.
    Type: Application
    Filed: July 6, 2009
    Publication date: May 27, 2010
    Applicant: Brown Technology Partnerships
    Inventors: Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Raymond Ferri, Alison Amenta, Mary Lynn Mercado, Hiroki Hagiwara
  • Patent number: 7612038
    Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.
    Type: Grant
    Filed: February 20, 2002
    Date of Patent: November 3, 2009
    Assignee: Brown University
    Inventors: Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Alison Amenta, Mary Lynn Mercado, Hiroki Hagiwara
  • Publication number: 20080274966
    Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Examples of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.
    Type: Application
    Filed: February 22, 2008
    Publication date: November 6, 2008
    Applicant: Brown University Research Foundation
    Inventors: Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Raymond Ferri
  • Patent number: 7335637
    Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Examples of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: February 26, 2008
    Assignee: Brown University Research Foundation
    Inventors: Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Raymond Ferri
  • Patent number: 6864236
    Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: March 8, 2005
    Assignee: Brown University Research Foundation
    Inventors: Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Raymond Ferri
  • Publication number: 20040063627
    Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.
    Type: Application
    Filed: February 20, 2002
    Publication date: April 1, 2004
    Inventors: Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Raymond Ferri